Skip to content

Evaluation the intra chest wall muscle injection effect on post breast surgery

Evaluation the efficacy of serratus anterior block on post mastectomy and mammaplasty pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016011810599N6
Enrollment
60
Registered
2017-01-06
Start date
2016-11-03
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post mastectomy and mamoplasty pain. Contusion of breast

Interventions

Intervention 1: Intervention group, sonographic guided anterior serratus block is made with 0.3 cc/kg of bupivacaine 0.2%, and then IV infusion pump is prescribed with the volume of 50 cc (fentanyl 15
Treatment - Other
Intervention group, sonographic guided anterior serratus block is made with 0.3 cc/kg of bupivacaine 0.2%, and then IV infusion pump is prescribed with the volume of 50 cc (fentanyl 15 cc + normal sal
Control group, only the infusion pump with the same contents and setting is prescribed

Sponsors

Vice Chancellor for Research Iran University Of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria... Patients with 20-60 years of age candidates for the elective breast surgery; ASA class I-II Exclusion criteria… Emergency surgery; Patient refusal; Coagulopathy; Addiction to any opioids or psychoaffective drugs; Anxiety disorders or depression; Any intraoperative complication

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 1 and 6 and 12 and 24 hours after block. Method of measurement: VAS (visual analog scale).

Secondary

MeasureTime frame
Opioid necessity. Timepoint: 1 and 6 and 12 and 24 hours after block. Method of measurement: The volume of drug use in pain management pumps.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactValiyan Borujeni Banafshe

Iran University of Medical Sciences

banafshe6937@yahoo.com+98 21 6435 2107

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026